Clinical Trial Update: A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections [NA]

View source ↗

Summary

A ClinicalTrials.gov registry entry for a study of ParActin® in individuals with upper respiratory tract infections; phase is not specified and the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• ParActin®

Snippet

Sponsor: Vedic Lifesciences Pvt. Ltd. | Conditions: Upper Respiratory Tract Infections | NA | Status: UNKNOWN